|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Realized gain from sales of trading securities | |||||
| Unrealized loss from trading securities | |||||
| Interest income | |||||
| Total other income | |||||
| Net loss | |||||
| Net loss per basic common share | |||||
| Net loss per diluted common share | |||||
| Basic | |||||
| Diluted | |||||
Loading...